학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 19건 | 목록
1~20
Academic Journal
Khan, AA; Paget, JT; McLaughlin, M; Kyula, JN; Wilkinson, MJ; Pencavel, T; Mansfield, D; Roulstone, V; Seth, R; Halle, M
SCIENCE TRANSLATIONAL MEDICINE. 10(425)
Academic Journal
McLaughlin, M; Pedersen, M; Roulstone, V; Bergerhoff, KF; Smith, HG; Whittock, H; Kyula, JN; Dillon, MT; Pandha, HS; Vile, R; Melcher, AA; Harrington, KJ
Mol Ther Oncolytics
Molecular Therapy: Oncolytics, Vol 16, Iss, Pp 238-249 (2020)
Molecular Therapy: Oncolytics, Vol 16, Iss, Pp 238-249 (2020)
Academic Journal
Mansfield, DC; Kyula, JN; Rosenfelder, N; Chao-Chu, J; Kramer-Marek, G; Khan, AA; Roulstone, V; McLaughlin, M; Melcher, AA; Vile, RG; Pandha, HS; Khoo, V; Harrington, KJ
Gene Ther
Academic Journal
Expert Opinion on Biological Therapy. 12:1669-1678
Academic Journal
Thomas, S; Kuncheria, L; Roulstone, V; Kyula, JN; Mansfield, D; Bommareddy, PK; Smith, H; Kaufman, HL; Harrington, KJ; Coffin, RS
J Immunother Cancer
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-17 (2019)
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-17 (2019)
Academic Journal
Kyula, JN; Khan, AA; Mansfield, D; Karapanagiotou, EM; Mclaughlin, M; Roulstone, V; Zaidi, S; Pencavel, T; Touchefeu, Y; Seth, R; Chen, NG; Yu, YA; Zhang, Q; Melcher, AA; Vile, RG; Pandha, HS; Ajaz, M; Szalay, AA; Harrington, KJ
Oncogene. 33:1700-1712
Academic Journal
Mansfield, D; Pencavel, T; Kyula, JN; Zaidi, S; Roulstone, V; Thway, K; Karapanagiotou, L; Khan, AA; McLaughlin, M; Touchefeu, Y; Seth, R; Melcher, AA; Vile, RG; Pandha, HS; Harrington, KJ
Oral Oncology. 49:108-118
Academic Journal
Roulstone, V; Twigger, K; Zaidi, S; Pencavel, T; Kyula, JN; White, C; McLaughlin, M; Seth, R; Karapanagiotou, EM; Mansfield, D; Coffey, M; Nuovo, G; Vile, RG; Pandha, HS; Melcher, AA; Harrington, KJ
Gene Therapy. 20:521-528
Academic Journal
McLaughlin, M; Barker, HE; Khan, AA; Pedersen, M; Dillon, M; Mansfield, DC; Patel, R; Kyula, JN; Bhide, SA; Newbold, KL; Nutting, CM; Harrington, KJ
BMC Cancer
Academic Journal
Hafsi H; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; Dillon MT; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden Hospital, London, United Kingdom.; Barker HE; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; Kyula JN; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; Schick U; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; Radiation Oncology Department, University Hospital Morvan, Brest, France.; Paget JT; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden Hospital, London, United Kingdom.; Smith HG; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden Hospital, London, United Kingdom.; Pedersen M; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; McLaughlin M; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; Harrington KJ; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden Hospital, London, United Kingdom.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Academic Journal
Seth R; London, Surrey, and Leeds, United Kingdom; and Rochester, Minn. From the Targeted Therapy Team, Institute of Cancer Research; the Department of Plastic Surgery, Royal Marsden Hospital; the Postgraduate Medical School, University of Guildford; the Leeds Institute of Molecular Medicine; and the Molecular Medicine Program, Mayo Clinic.; Khan AA; Pencavel TD; Wilkinson MJ; Kyula JN; Simpson G; Pandha H; Melcher A; Vile R; Harris PA; Harrington KJ
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 1306050 Publication Model: Print Cited Medium: Internet ISSN: 1529-4242 (Electronic) Linking ISSN: 00321052 NLM ISO Abbreviation: Plast Reconstr Surg Subsets: MEDLINE
Editorial & Opinion
Kyula JN; Department of cancer biology, Institute of Cancer Research, London.; Khan AA; Wilkinson MJ; Mansfield D; Harrington KJ
Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE
Academic Journal
Borst GR; The Institute of Cancer Research, London, United Kingdom. g.borst@nki.nl; McLaughlin M; Kyula JN; Neijenhuis S; Khan A; Good J; Zaidi S; Powell NG; Meier P; Collins I; Garrett MD; Verheij M; Harrington KJ
Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE
Academic Journal
Van Schaeybroeck S; Drug Resistance Group, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland.; Kyula JN; Fenton A; Fenning CS; Sasazuki T; Shirasawa S; Longley DB; Johnston PG
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Academic Journal
Kyula JN; Drug Resistance Group, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland.; Van Schaeybroeck S; Doherty J; Fenning CS; Longley DB; Johnston PG
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Chan Wah Hak C; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; Patin EC; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; Patrikeev A; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; Nicastri A; Functional Proteomics Group, The Institute of Cancer Research, London, United Kingdom.; Kozik Z; Functional Proteomics Group, The Institute of Cancer Research, London, United Kingdom.; Baldock H; Biological Services Unit, The Institute of Cancer Research, London, United Kingdom.; Kyula-Currie JN; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; Roulstone V; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; Wongariyapak A; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; Gifford V; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.; Tenev T; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.; Appleton ES; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; Hubbard LC; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; Foo S; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; Pedersen M; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; Choudhary JS; Functional Proteomics Group, The Institute of Cancer Research, London, United Kingdom.; Ono M; Department of Life Sciences, Faculty of Natural Sciences, Imperial College London, London, United Kingdom.; Melcher AA; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; Rullan A; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; Harrington KJ; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE
CXCL12-Targeted Immunomodulatory Gene Therapy Reduces Radiation-Induced Fibrosis in Healthy Tissues.
Academic Journal
Paget JT; Chester Beatty Laboratories, Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.; Ward JA; Chester Beatty Laboratories, Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.; McKean AR; Chester Beatty Laboratories, Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.; Mansfield DC; Chester Beatty Laboratories, Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.; McLaughlin M; Chester Beatty Laboratories, Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.; Kyula-Currie JN; Chester Beatty Laboratories, Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.; Smith HG; Chester Beatty Laboratories, Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.; Roulstone V; Chester Beatty Laboratories, Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.; Li C; Division of Infection and Immunity, School of Medicine, Systems Immunity University Research Institute, Cardiff University, Cardiff, United Kingdom.; Zhou Y; Division of Infection and Immunity, School of Medicine, Systems Immunity University Research Institute, Cardiff University, Cardiff, United Kingdom.; Hardiman T; Cancer Bioinformatics Group, King's College, London, United Kingdom.; Grigoriadis A; Cancer Bioinformatics Group, King's College, London, United Kingdom.; O'Brien Coon D; Department of Biomedical Engineering, Translational Tissue Engineering Center, Johns Hopkins University Whiting School of Engineering, Baltimore, Maryland.; Irshad S; Division of Cancer and Pharmaceutical Sciences, King's College, London, United Kingdom.; Melcher AA; Chester Beatty Laboratories, Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.; Harrington KJ; Chester Beatty Laboratories, Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.; Khan A; Chester Beatty Laboratories, Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.
Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Academic Journal
Smith HG; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.; The Sarcoma Unit, Department of Academic Surgery, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom.; Mansfield D; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.; Roulstone V; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.; Kyula-Currie JN; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.; McLaughlin M; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.; Patel RR; Flow Cytometry and Light Microscopy Facility, The Institute of Cancer Research, London, United Kingdom.; Bergerhoff KF; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.; Paget JT; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.; Dillon MT; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.; Khan A; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.; Melcher A; Translational Immunotherapy Team, The Institute of Cancer Research, London, United Kingdom.; Thway K; The Sarcoma Unit, Department of Academic Surgery, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom.; Harrington KJ; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom. Kevin.Harrington@icr.ac.uk.; Hayes AJ; The Sarcoma Unit, Department of Academic Surgery, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Kyula, JN
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어